Clinical Conversations: How JAK Inhibitors are Changing the AD Treatment Landscape

Clinical Conversations How JAK Inhibitors are Changing the AD Treatment Landscape thumbnail

Media formats available:

Recommended

Tolerability of JAK Inhibitors Used in Dermatology
Tolerability of JAK Inhibitors Used in Dermatology
JAK Inhibitors in Practice
Tolerability of JAK Inhibitors Used in Dermatology
- Matthew J. Zirwas, MD
- Adelaide Hebert, MD
Clinical Conversations: Risks vs Benefits of JAK Inhibitors
Clinical Conversations: Risks vs Benefits of JAK Inhibitors
JAK Inhibitors in Practice
Clinical Conversations: Risks vs Benefits of JAK Inhibitors
- Matthew J. Zirwas, MD
- Adelaide Hebert, MD
Clinical Conversations: The Data for JAK Inhibitors in AD
Clinical Conversations: The Data for JAK Inhibitors in AD
JAK Inhibitors in Practice
Clinical Conversations: The Data for JAK Inhibitors in AD
- Brad Glick, DO, MPH
- Raj Chovatiya, MD, PhD
Clinical Conversations: MOA of JAK Inhibitors in Dermatology
Clinical Conversations: MOA of JAK Inhibitors in Dermatology
JAK Inhibitors in Practice
Clinical Conversations: MOA of JAK Inhibitors in Dermatology
- Brad Glick, DO, MPH
- Raj Chovatiya, MD, PhD